Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Oct 20, 2025
Reporting period
Not applicable
Filed with the SEC
Oct 22, 2025
CEOOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references tax withholding
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001903669-25-000003
Filed / recorded
Oct 22, 2025, 8:15 PM UTC
Added to OQRO
Oct 7, 2026, 5:52 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
SPRUCE BIOSCIENCES, INC.
Issuer CIK
1683553
Ticker
SPRB
Reporting person
Javier B. Szwarcberg
Relationship
Director, Officer
Officer title
CHIEF EXECUTIVE OFFICER
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Oct 20, 2025
Transaction code
M
Shares / units
4,784
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
11,013
Ownership form
Direct
Amendment
No
Footnotes from the filing
On March 14, 2024, the Reporting Person was granted 4,784 performance-based RSUs. On October 20, 2025, the Issuer's Board of Directors certified that certain specified performance goals were met and all of the RSUs vested. 1,539 shares were withheld for taxes, resulting in a net issuance of 3,245 shares.
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of SPRB common stock.